Directory · NO
Biotechnology Research in Norway
A register of firms and the professionals working at them in the Biotechnology Research sector based in Norway. Browse the public index, then filter or export on Kipplo.
Companies
149 on file
Aker Biomarine Asa
Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. We bring our nutrient-rich, all-natural krill ingredient to the pharmaceutical and nutraceutical markets through our leading brands: Superba Krill Oil, Lysoveta, Understory, and Kori Krill. Our innovative approach also extends into our spin-offs FloraMarine (plant-based source of omega-3 from algae), AION (reduce and recycle plastic waste across industries), and Understory (our protein brand). The brand results from our belief that krill is an ancient natural resource and a nutritional opportunity to improve life on our planet. Aker BioMarine is listed on Oslo Stock Exchange (AKBM).
201 to 500 staff
Eurofins Norway
Eurofins Scientific er et internasjonalt konsern som tilbyr et unikt utvalg av analysetjenester som påvirker liv, helse og miljø for et vidt spekter av bransjer. Gruppen anses å være verdensledende innen mat, miljø og farmasøytiske produkttester samt innen agrovitenskap. Gruppen er også en av de globale uavhengige markedslederne av visse analyser og laboratorietjenester innen genomikk, farmakologi, rettsmedisin, CDMO, avanserte materialvitenskap og som støtte for kliniske studier. I tillegg er Eurofins en av de viktigste fremvoksende aktørene innen klinisk diagnostisk testing i Europa og USA. Eurofins internasjonale nettverk består av mer enn 900 laboratorier i over 60 land, med over ansatte. Porteføljen består av mer enn analysemetoder og mer enn 450 millioner tester utføres årlig. I 2022 hadde Eurofins 6,7 milliarder euro i omsetning. Eurofins i Norge har over 220 ansatte, hovedkontor og laboratorium i Moss og laboratorier i Oslo, Kristiansand, Klepp, Bergen, Florø, Ålesund, Trondheim, Sortland og Alta. Vi utfører kjemiske, mikrobiologiske og sensoriske laboratorieanalyser, samt prøvetaking og rådgivning innen områdene miljø, mat/fôr, landbruk og produkter/kjemikalier. Eurofins bygger virksomheten på våre grunnverdier; kundefokus, kvalitet, kompetanse, lagånd og integritet.
201 to 500 staff
Benchmark Genetics
Benchmark Genetics is a leader in aquaculture genetics, focusing on salmon and shrimp genetics with three in-house breeding programs. With experience from over 40 applied breeding programs, and 30 species, across 16 countries, we provide genetic services for various species worldwide. Our breeding centers are in Norway, Iceland, the USA, and Colombia. We prioritize innovation through modern breeding technologies like QTL and Genomic Selection while staying customer-focused through long-standing partnerships. Our technical support ensures that our customers can maximize the potential of our genetics. The company offers Genotyping services and tools for a wide range of aquatic species at competitive prices. Contact us today for an offer.
201 to 500 staff
Pharmaq Analytiq As
PHARMAQ Analytiq tilbyr analyser og rådgivning som gir innsikt i smoltifisering, sykdomsstatus og fiskehelse. Vi benytter molekylærbiologiske metoder som gir deg en konkret og objektiv status på tilstedeværelse og mengde av virus, bakterier og parasitter. Smoltifisering påvirkes av en rekke faktorer slik som lys, temperatur, vannkvalitet og genetikk. PHARMAQ Analytiq har analysert smolt i over 15 år og tilbyr i dag et solid styringsverktøy for optimalisering av smoltutsett.
11 to 50 staff
Gc Rieber Vivomega As
GC Rieber VivoMega is the exclusive manufacturer of VivoMega – a high-quality, concentrated marine Omega-3. We are committed to improving human health through superior Omega-3s, delivered with sustainable and innovative solutions. Our production facility is located in Kristiansund, on the northwest coast of Norway. Visit our website to learn more.
51 to 200 staff
Oncoinvent Asa
Oncoinvent is a clinical stage company committed to developing new innovative radiopharmaceutical products for better treatment options for cancer patients. Radspherin®, the company’s lead product candidate is a novel alpha-emitting radioactive microsphere suspension designed for treatment of metastatic cancers in body cavities. Radspherin® has shown strong and consistent anticancer activity at essentially non-toxic doses in preclinical studies and is anticipated to potentially treat several forms of metastatic cancer. Situated in Oslo, Oncoinvent’s main offices include modern laboratory facilities suitable for cGMP and radiopharmaceutical manufacture for clinical trials and research. The development programs of the company include radiotherapeutic and radioimmunotherapeutic products with focus on alpha-emitting radionuclides for treatment of various solid cancers.
11 to 50 staff
Exact Therapeutics
EXACT Therapeutics ("EXACT-Tx") is a clinical-stage biopharmaceutical company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.
1 to 10 staff
Pre Diagnostics As
We develop blood-based biomarkers for the early detection of neurodegenerative diseases. Our biomarkers can be applied for diagnostic as well as drug development purposes. The first product detects Alzheimer's disease before clinical symptoms appear. In the pipeline we have blood based biomarkers for Parkinson's as well as a biomarker for ARIA management.
1 to 10 staff
Bio-Me
Bio-Me AS is a service provider specialized in microbiome analysis. Bio-Me’s innovative technology for Precision Microbiome Profiling (PMP™) enables the accurate, rapid, and cost-competitive routine analysis of the gut, skin and vaginal microbiome. Backed by a proprietary assay database and platform for PMP™ assay design, Bio-Me also offers custom development of standardized & validated assays for microbiome routine testing. Based in Oslo, Norway, Bio-Me partners with leading healthcare institutions as well as pharmaceutical and consumer care companies worldwide.
11 to 50 staff
Calpro As
Calpro AS was founded by the inventors of the technology behind the ELISA kits for determination of calprotectin in stools and other biological materials. The company is based in Oslo and has the benefit of close professional links with many of the major clinical research departments and medical establishments in Norway, Europe and the USA. Calpro AS provides high quality total solution for Calprotectin analysis. From fully automated system, to home monitoring of patients with IBD. The CalproLab™ELISA kit is validated for testing on faeces, plasma/serum samples, enabling among others assessment of IBD, rheumatic diseases and distinction between bacterial and viral infections. EasyExtract™ Prefilled faces extraction device for extraction and sampling. Ideal for home sampling. Fits straight into Dynex Ds2 ELISA. The CalproSmart™ kit is validated and approved for self-testing, and is used for monitoring IBD treatment using a SMART phone, trending the quantitative levels of Calprotectin, and improving patient quality of life. High quality products from Calpro AS are being distributed worldwide.
1 to 10 staff
Hemispherian As
Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Our mission is to develop a new drug to treat Glioblastoma Multiforme. We aim to significantly increase life expectancy for patients, improve patient comfort, and generally increase the overall survival rates for GBM patients.
11 to 50 staff
Kappa Bioscience, A Balchem Company
At Kappa, we believe in better health for all. But better health for all can only work when we all work together. So we don't have customers here. We only have partners, both within our company, and in the companies we work with. Partners we work with as equals, to build strong, lasting relationships that help us succeed in transforming lives. We pioneered the large-scale manufacturing of biologically active all-trans menaquinone-7 (vitamin K2 MK-7) or as we like to call it, K2VITAL®. And to this day, we proudly continue that legacy of innovation. We’re a bioscience company through and through, with teams of passionate experts and a state-of-the-art GMP-certified API contract laboratory that helps us make pure vitamin K2 MK-7 in ground-breaking new forms, with unmatched quality, stability. And to make it available to everyone. We pride ourselves on finding like-minded partners that share our passion for all the exciting possibilities of vitamin K2, and our vision to change our industry by doing things differently. Maybe it would be easier to do things the way they’ve always been done, but that’s simply not why we get out of bed in the morning. We’re here to do it right. Founded and headquartered in Oslo, Norway, Kappa Bioscience has been a company of Balchem Corporation, a US-based global specialty ingredients company focused on nutrition and health, since 2022.
51 to 200 staff
Labora
Labora er et analyselaboratorium og en fiskehelsetjeneste lokalisert i Bodø, trafikknutepunktet i Nordland. Fordi vi har kjennskap til Nord-Norge og alle kriker, kroker og øyer, er vi godt dreven på å løse logistikkutfordringer ved innsending av prøver. Labora er pålitelig og leverer nøyaktige resultat med konfidensiell og upartisk håndtering. Vi er hjelpsomme, og gir råd for å forebygge sykdom og smitte. Vi er i beredskap og hjelper til med behandling om krisen først oppstår, og er tett på din problemstilling og oppfølging i ettertid. Labora jobber for å holde folk og næring i nord friske og trygge. Vi har bygget kompetanse i 60 år, og vi vet hva som skal til for at ditt drikkevann, oppdrettsanlegg, produksjonsmiljø, slakteri, miljøstasjon, dusjanlegg, avløp eller skip skal være hygienisk og trygt.
11 to 50 staff
Matriks As
Matriks er en av Norges største leverandører til laboratoriemarkedet i Norge og leverer utstyr innen kromatografi, massespektrometri, spektroskopi, elementanalysatorer m.m. Vår viktigste leverandør er Agilent Technologies som er verdensledende innen kromatografi og massespektrometri. Matriks AS har lang erfaring innen disse områdene og har en stor installert base.
11 to 50 staff
Nykode Therapeutics
We are a leading technology platform that unlocks unlimited possibilities for the future of medicine through our intelligent modular design and tailored hyper targeting.
51 to 200 staff
Patogen As
PatoGen er et bioteknologiselskap som bistår akvakulturnæringen i fiskehelserelaterte utfordringer. Vi tilbyr tjenester til forebyggende fiskehelse og diagnostikk ved bruk av Real Time PCR, sekvensering, histologi og bakteriologi. Siden starten har PatoGen vært en viktig pådriver og premissleverandør for bærekraftig vekst i oppdrettsnæringen. Med visjonen «We inspire actions for healthier fish» skal vi fortsette å gå i spissen for utviklingen av dette viktige fagområdet. PatoGen har hovedkontor i Ålesund, og avdelinger i Bodø, Oslo og Oban (Skottland). PatoGen er akkreditert av Norsk Akkreditering etter internasjonal standard ISO17025.
51 to 200 staff
Previwo
Previwo is a Norwegian based biotechnology company, where we make use of probiotic bacteria to enhance productivity of healthy, thriving fish and new science and technology to make more effective vaccines for salmon aquaculture. We take a new scientific approach to the discoveries outside the current frame of thought, resulting in strategies with a deep product pipeline combining use strategies for products with patented probiotic and vaccine strains.
11 to 50 staff
Genetic Analysis As
Genetic Analysis AS (GA) is positioned to become a world leader within the field of molecular in-vitro diagnostics of diseases related to gut imbalances. Based on the patented DNA-based GA-map® platform technology, profiles of patient’s gut microbiota is quickly generated and can be related to various health conditions. Our first product, the GA-map® Dysbiosis Test helps Gastroenterologists to measure and monitor gut microbiota status in patients with Irritable Bowel Syndrome (IBS). This is the first dysbiosis test which is commercially available, standardised, CE-marked and clinically validated (50 clinical trials + 30 publications). Further clinical applications for the tests are in areas such as diagnosis, disease severity course, treatment prediction and monitoring within both IBS (irritable bowel syndrome) and IBD (inflammatory bowel disease) where the need of clinical data and validation is required. GA is thus very active in these fields. Other areas of interest are metabolic disease including diabetes type 2.
11 to 50 staff
Alginor Asa
Alginor seeks towards a green and sustainable future based on treasures from the sea. We focus on total utilisation of seaweeds for production of unique, pure and formula-specific products. Through green, environmentally friendly and resource efficient operations Alginor sets the standard for tomorrow’s innovative solutions. Alginor ASA was established 24th of March 2014 in Haugesund, Norway to develop a technology for total utilisation of seaweeds to be integrated in a multifunctional biorefinery for seaweeds. Seaweeds are among the world’s largest untapped resources. We are focusing on the large brown kelp Laminaria hyperborea and along the Norwegian coast alone there is a rough estimate of 60 million tonnes of standing biomass. To secure a sustainable and efficient utilisation of this important stock it is necessary to exploit the entire biomass. We plan to establish the first biorefinery in Norway that focuses on total utilisation of seaweeds and extracting pure and formula-specific products for application areas such as food, feed, pharma, agri, chemicals and materials.
11 to 50 staff
Amicoat
Amicoat AS is a Norwegian biotechnology company that discovers, develops, and commercializes novel antimicrobial science with broad applications across diverse industries. Our current focus is on medical devices.
11 to 50 staff
Calluna Pharma
Our innovative therapeutic approach targets upstream amplifiers of disease offering potential treatments across a diverse array of therapeutic indications. Calluna Pharma is a clinical stage biotech company driven by a commitment to improve patient outcomes in diseases where existing treatments are sub-optimal. We believe in the power of immunology to push boundaries, challenge the status quo, and develop therapies that will make a real difference for people living with serious diseases.
11 to 50 staff
Circio Holding Asa
Circio Holding ASA is a clinical stage company developing immune activators to target difficult-to-treat diseases. The company’s mission is to deploy vector-based technology to create a novel class of targeted, multi-functional circRNA medicines. It has established a cutting-edge circular RNA (circRNA) program and is collaborating with Prof Michael Uhlin and a team at the Karolinska Institutet in Stockholm with the intent to develop next generation RNA therapeutics for various applications. The company also has a mutant RAS cancer vaccine program, with two collaborative clinical trials underway in the USA and Norway. It is currently looking at options for the financing of a phase 2 study for ONCOS-102, a genetically modified oncolytic adenovirus.
11 to 50 staff
Oslo Cancer Cluster
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines. We are a national non-profit member organization with about 90 members. Our members are Norwegian and international companies, research and financial institutions, university hospitals, and organizations – all working in the cancer field. They represent the entire oncology value chain, doing everything from exploratory research to selling therapeutics and diagnostics to global markets. Our Incubator Environment Around 30 of the members are gathered in the Oslo Cancer Cluster Incubator, a successful biotech cluster, situated in the Oslo Cancer Cluster Innovation Park. We share the innovation park with Ullern Upper Secondary School, the Cancer Registry of Norway, several innovative companies, and Oslo University Hospital. Please follow the incubator LinkedIn page for news about the incubator companies: Twitter and Facebook:@oslocancer info@oslocancercluster.no
11 to 50 staff
Planktonic As
Planktonic has been selling CryoPlankton since 2016 and is now a progressive and leading supplier of live feed to marine hatcheries in Europe. At Planktonic, we believe in challenging conventional practices. Adding more complexity to existing solutions is not progression, simplicity is the ultimate sophistication. We are committed to delivering the world’s best and easiest live feed. Our foundation is the idea of developing sustainable feed solutions based on natural marine plankton. Our mission is to simplify the production process in hatcheries, reduce risk and increase biosecurity, while improving fry quality and increase FCR in growth cages. See for more information about our product, CryoPlankton.
11 to 50 staff
